Tofacitinib- A First-In-Class Drug for Rheumatoid Arthritis

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2017, Vol 16, Issue 3

Abstract

Rheumatoid arthritis (RA) is a chronic, systemic and disabling autoimmune inflammatory disease characterized by inflammation of the synovial lining of the joints, tendons and periarticular structure affecting approximately 1% of the population world-wide. Tofacitinib is a novel oral Janus-kinase inhibitor approved for the treatment of RA patients as a second line therapy in those who fail to respond to methotrexate therapy. Clinical trials with tofacitinib have shown reasonable efficacy. However, the drug’s greatest limitation is its potential to induce cancers and latent infections could be reactivated. Nevertheless, the drug can slow the progression of the disease and has evoked lot of interest due to the fact that it is a first in class molecule for the treatment of rheumatoid arthritis.

Authors and Affiliations

Sujithera Haridoss, Melvin George, Damal Kandadai Sriram

Keywords

Related Articles

Clinico- Etiological Study of Urticaria in a Tertiary Care Hospital

In spite of frequency of Acute&chronic urticaria there are few studies of its prevalence and causes, aetiology. Appropriate management of urticaria depends on the correct evaluation of clinical patterns and causes where...

Prevalence of Depression And Its Associated Factor With Coping Strategies Among Medically Ill Elderly Patients In Eastern Rajasthan Jaipur

Background: Depression is recognized as a serious public health concern in developing countries. It is the most common psychiatric disorder among the elder person. There is a relationship between coping and depression. I...

Assessment of Clinical and Biochemical Profile of Prediabetic Subject in Bangladesh, Attending in BIRDEM and results of Intervention by Lifestyle Modification, Metformin, and DPP4 Inhibitor

Prediabetes is a reversible condition that increases an individual’s risk for progress to diabetes.The aim of the study is to assess prediabetic profile before and after life style modification only, lifestyle with metfo...

Study Of Outcome Of Chemical Cauterisation Of Cases Of Small Central Perforation Of Tympanic Membrane In A Tertiary Care Hospital In North East India.

Central perforation of tympanic membrane of fifty patients were cauterized with 30 percent trichloroacetic acid having around 1-6mm size of perforation.Most of the cases that were undertaken were post traumatic and infla...

A Study Of Pattern Of Various Skin Diseases In Patients Attending To SKIN OPD, RIMS General Hospital, Srikakulam, Andhrapradesh.

Background: There has been a rise in the magnitude of dermatological diseases in India. It is generally agreed that the pattern of skin diseases differs in different countries, and within the various regions of same coun...

Download PDF file
  • EP ID EP591706
  • DOI 10.9790/0853-160301106108
  • Views 75
  • Downloads 0

How To Cite

Sujithera Haridoss, Melvin George, Damal Kandadai Sriram (2017). Tofacitinib- A First-In-Class Drug for Rheumatoid Arthritis. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 16(3), 106-108. https://europub.co.uk/articles/-A-591706